The Innovative Cartilage Repair Solution, A Participatory Project!
ACS Biotech has chosen the participatory economy to reaffirm its values and allow investors to give meaning to their savings while financing the real economy on a major public health issue.
ACS Biotech has developed a unique injectable product for the repair of cartilage lesions occurring following trauma or a degenerative disease such as osteoarthritis or osteochondritis dissecans.
Our strategy of combining the properties of a hydrogel environment (natural polymer, biodegradable, biocompatible, regeneration of the target tissue) with perfectly controlled cartilage cells, has made it possible to develop an articular cartilage gel ready for implantation, validated as part of a research program with the CNRS. This innovation has been protected by a portfolio of 9 patents since 2014.
Our first fundraising campaign was a great success. Thanks to you, partners and shareholders, as well as the support of banks and the European community (Eurostars winner), our first fundraising led us to validate the performance and safety of our product within the framework pre-clinical tests.